Ian Taylor Email & Phone Number

Wimborne, Dorset

Sector: Cell Line Development, ImagingRole: Developed the strategic sales and marketing planSold first systems to early adopters in US and EuropeBased on initial success, developed next level strategy for "early majority" customers.Developed global distribution and routes to marketDeveloping plans for product extensions and new products for cell line.

Hampshire

Interim consulting which performs the outsourcing of all commercial activities for a "portfolio" of spin-offs, early stage and medium-sized technology companies in the Med Tech and Pharma Tools sectors. This is an attractive option for small businesses to get the highest calibre resource but avoid the overhead of a full-time position or sales teamLocation.

Oxford

Sectors: Pharma Services; 3-D cell culture; liver hepatotoxicity, infectious diseasesTaylormade Sales clientRole: Build on strong validated data from early customers using the in vitro liver model platform.Develop commercial strategies, sales tools and pipeline for "early majority" customers

Oxford

Sector: Med TechTaylormade Sales ClientRole: write the business plan to support next round of funding.

Bonn, Germany

Sectors: Protein biosensors, microfluidics, biomaterials, nanotechnologyTaylormade Sales clientRoles: Establishing all sales and marketing functions for new biosensor company.Establishing new sales channels directly in US and via distributors in Europe and Asia-Pacific.Major achievement: establishing the technology as a displacement technology versus SPR.

Ringwood, UK

Sector: Chemistry, Flow Cytometry, IVDOut-licensing novel Nobel Prize-winning polymer chemistry which significantly boosts conventional fluorescence labels eiminating many of the drawbacks of incumbent labelling approaches (phycobiliproteins, quantum dots, chemiluminescence). Major implications for immuno and molecular diagnostics.Responsible for all.

Cambridgeshire

Sector: BioreactorsThis was a Board position.Establishing sales and marketing infrastructure for early-stage companyIncluding routes to market via distributors in Europe and USCompany was unable to secure next round of funding and went into liquidation in March 2008

New Milton, Hampshire

Sector: Genomics, Proteomics, Cell Biology, Therapeutic Antibodies, ImagingResponsible for switch in product range from genomics to cell biology using core strengths of Genetix.Re-built US sales team and infrastructure.Changed customer base from academic to industrial and moved sales process to be based upon return on investment proposals.Managed a sales.

Boston, US

Sector: genomics, proteomicsResponsible for global business strategy, sales and marketing of the complete proteomics portfolio from PerkinElmer.Trebled the turnover of the business unit to $6Mi per annumReporting directly to President of Life Sciences, Patrick Dahlen

Cambridgeshire

Sector: Microarray and ProteomicsResponsible for building sales/marketing/serviceResponsible for integrating this business into Perkin Elmer

Hertford, UK

Sector: Chromatography, Mass SpectrometryEuropean Sales Person of the Year.Repsonsible for sales and business development for all major pharma accounts in UK.

Milton Keynes

Sector - HTS and Time-resolved fluorescencePharma specialistEuropean sales person of the year

Southampton

Trainee Chartered Accountant ACCA

Doctor Of Philosophy (Ph.D.), Biochemistry, Molecular Biology, Protein Biochemistry

Working for Dr David O'Connor

B.Sc Honours, Biochemistry With Physiology, First Class

One of only two people in the Class of 86 to obtain a First